Total records found: 1622
Hide HeadlineShow Headline
Sort
Release Time Stock Code Stock Short Name Document
Release Time: 26/10/2026 19:26 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - RESULTS FROM A PHASE III CLINICAL STUDY OF ANBENITAMAB IN COMBINATION WITH DOCETAXEL FOR INJECTION (ALBUMIN-BOUND) (HB1801) FOR THE FIRST-LINE TREATMENT OF HER2-POSITIVE ADVANCED BREAST CANCER PRESENTED AS A PROFFERED PAPER PRESENTATION AT THE ESMO CONGRESS 2026 AND SIMULTANEOUSLY PUBLISHED IN THE NEW ENGLAND JOURNAL OF MEDICINE (96KB)
Release Time: 26/10/2026 19:23 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - UPDATED OVERALL SURVIVAL (OS) RESULTS FROM A PHASE III CLINICAL STUDY OF ANBENITAMAB FOR THE TREATMENT OF HER2-POSITIVE ADVANCED GASTRIC CANCER/GASTRO-OESOPHAGEAL JUNCTION ADENOCARCINOMA PRESENTED AS A RAPID ORAL PRESENTATION AT THE ESMO CONGRESS 2026 (88KB)
Release Time: 23/10/2026 08:00 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - BATOCLIMAB INJECTION (SUBCUTANEOUS INJECTION) OBTAINS DRUG REGISTRATION CERTIFICATE FROM THE NMPA (99KB)
Release Time: 22/10/2026 18:31 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL TRIAL OF SYS6043 FOR THE FIRST-LINE TREATMENT OF UNRESECTABLE RECURRENT OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER OFFICIALLY INITIATED IN CHINA (67KB)
Release Time: 22/10/2026 18:26 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF SYH2066 FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS INFECTION OFFICIALLY INITIATED IN CHINA (67KB)
Release Time: 20/10/2026 18:11 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE I CLINICAL TRIAL OF SYH2083 EYE DROPS FOR THE TREATMENT OF DRY EYE DISEASE OFFICIALLY INITIATED IN CHINA (67KB)
Release Time: 16/10/2026 18:06 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Share Scheme]
VOLUNTARY ANNOUNCEMENT - GRANT OF AWARDED SHARES PURSUANT TO THE 2026 SHARE AWARD SCHEME (85KB)
Release Time: 15/10/2026 18:00 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Share Scheme]
VOLUNTARY ANNOUNCEMENT - GRANT OF AWARDED SHARES PURSUANT TO THE 2018 SHARE AWARD SCHEME (77KB)
Release Time: 15/10/2026 17:53 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - SYS6088 INJECTION (A TRI-SPECIFIC ANTIBODY) OBTAINS CLINICAL TRIAL APPROVAL IN CHINA (67KB)
Release Time: 15/10/2026 17:15 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - SYS6062 (ANTIBODY-DRUG CONJUGATE) OBTAINS CLINICAL TRIAL APPROVAL IN CHINA (65KB)
Release Time: 08/10/2026 18:22 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - DATA FROM PHASE I CLINICAL STUDY OF SYS6002 AS MONOTHERAPY FOR THE TREATMENT OF ADVANCED CERVICAL CANCER PRESENTED AS A RAPID ORAL PRESENTATION AT THE 2026 ANNUAL GLOBAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY (IGCS 2026) (73KB)
Release Time: 05/10/2026 18:50 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - LATEST UPDATES FROM 8 CLINICAL TRIALS TO BE PRESENTED AT THE ESMO CONGRESS 2026 (126KB)
Release Time: 02/10/2026 18:30 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Monthly Returns
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2026 (66KB)
Release Time: 30/09/2026 20:06 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - RESULTS OF PHASE III CLINICAL STUDY OF EFMEDAGLUTIDE ALFA INJECTION IN COMBINATION WITH METFORMIN IN CHINESE ADULT PATIENTS WITH TYPE 2 DIABETES MELLITUS PRESENTED IN A SHORT ORAL DISCUSSION AT THE 62ND ANNUAL MEETING OF THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES (EASD 2026) (79KB)
Release Time: 29/09/2026 18:03 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE IB CLINICAL TRIAL OF JMT206 INJECTION FOR WEIGHT MANAGEMENT IN ADULT PATIENTS WITH OVERWEIGHT OR OBESITY OFFICIALLY INITIATED AT THE FIRST STUDY CENTRE IN CHINA (68KB)
Release Time: 29/09/2026 18:00 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - RECOMBINANT HERPES ZOSTER VACCINE (SYS6052) OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S. (67KB)
Release Time: 28/09/2026 18:08 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - SYS6077 INJECTION OBTAINS CLINICAL TRIAL APPROVAL IN CHINA (71KB)
Release Time: 24/09/2026 20:08 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL TRIAL OF BECOTATUG (JMT101) IN COMBINATION WITH OSIMERTINIB FOR THE FIRST-LINE TREATMENT OF LOCALLY ADVANCED OR METASTATIC NSCLC HARBOURING EGFR EXON 20 INSERTION MUTATIONS ACHIEVES POSITIVE TOPLINE RESULTS (77KB)
Release Time: 24/09/2026 17:00 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL TRIAL OF DOCETAXEL FOR INJECTION (ALBUMIN-BOUND) (HB1801) FOR THE TREATMENT OF ADVANCED BREAST CANCER OFFICIALLY INITIATED IN CHINA (71KB)
Release Time: 17/09/2026 18:06 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Circulars - [Other]
NOTIFICATION LETTER TO NON-REGISTERED HOLDER AND REQUEST FORM (488KB)
Release Time: 17/09/2026 18:06 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Circulars - [Other]
NOTIFICATION LETTER TO SHAREHOLDER AND CHANGE REQUEST FORM (454KB)
Release Time: 17/09/2026 18:05 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Circulars - [Other]
LETTER TO NEW REGISTERED SHAREHOLDERS AND REPLY FORM (428KB)
Release Time: 17/09/2026 18:02 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Financial Statements/ESG Information - [Interim/Half-Year Report]
2026 INTERIM REPORT (2MB)
Release Time: 16/09/2026 18:37 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF SYH2069 INJECTION FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN ADULT PATIENTS OFFICIALLY INITIATED AT THE FIRST CENTRE IN CHINA (71KB)
Release Time: 15/09/2026 18:01 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - SYS6010 GRANTED BREAKTHROUGH THERAPY DESIGNATION BY NMPA IN CHINA FOR THE TREATMENT OF PATIENTS WITH ACTIONABLE GENOMIC ALTERATION-NEGATIVE NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (73KB)
Release Time: 14/09/2026 17:31 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE I/II CLINICAL TRIAL DATA OF SYS6010 IN COMBINATION WITH ENLONSTOBART FOR THE TREATMENT OF SYSTEMIC TREATMENT-NAIVE, ACTIONABLE GENOMIC ALTERATION-NEGATIVE ADVANCED NSCLC ORALLY PRESENTED AT THE 2026 WORLD CONFERENCE ON LUNG CANCER (WCLC) (77KB)
Release Time: 09/09/2026 18:08 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ROTIGOTINE LONG-ACTING INJECTION (SYH9087 INJECTION) OBTAINS CLINICAL TRIAL APPROVAL IN CHINA (68KB)
Release Time: 09/09/2026 18:06 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - GOSERELIN SUSTAINED-RELEASE INJECTION (SYH9102 INJECTION) OBTAINS CLINICAL TRIAL APPROVAL IN CHINA (69KB)
Release Time: 08/09/2026 17:46 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - INNOVATIVE CHEMICAL DRUG SYH2083 EYE DROPS OBTAIN CLINICAL TRIAL APPROVAL IN CHINA (65KB)
Release Time: 07/09/2026 19:26 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF SYH2085 TABLETS FOR THE TREATMENT OF UNCOMPLICATED INFLUENZA IN ADULTS OFFICIALLY INITIATED IN CHINA (72KB)
Release Time: 01/09/2026 18:08 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE I CLINICAL TRIAL OF SYH2056 TABLETS FOR THE TREATMENT OF DEPRESSION OFFICIALLY INITIATED IN CHINA (67KB)
Release Time: 01/09/2026 18:06 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - SYS6010 GRANTED ANOTHER BREAKTHROUGH THERAPY DESIGNATION BY THE NMPA IN CHINA FOR THE TREATMENT OF PATIENTS WITH RECURRENT OR METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA (72KB)
Release Time: 01/09/2026 18:04 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Monthly Returns
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2026 (66KB)
Release Time: 31/08/2026 19:51 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE I CLINICAL TRIAL OF SYH2092 INJECTION FOR WEIGHT MANAGEMENT IN ADULT PATIENTS WITH OVERWEIGHT OR OBESITY OFFICIALLY INITIATED AT THE FIRST CENTRE IN CHINA (67KB)
Release Time: 28/08/2026 16:30 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF SYH2069 INJECTION FOR WEIGHT MANAGEMENT IN ADULT PATIENTS WITH OVERWEIGHT OR OBESITY OFFICIALLY INITIATED AT THE FIRST CENTRE IN CHINA (74KB)
Release Time: 27/08/2026 18:18 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - HIGHLY POTENT AMYLIN RECEPTOR AGONIST (SYH2092 INJECTION) OBTAINS CLINICAL TRIAL APPROVAL IN CHINA (71KB)
Release Time: 26/08/2026 18:09 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - SYS6090 (JMT108) GRANTED FAST TRACK DESIGNATION BY U.S. FDA FOR TREATMENT OF PATIENTS WITH MSS/pMMR mCRC (70KB)
Release Time: 26/08/2026 18:01 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL STUDY OF SYS6010 FOR EGFR-MUTATED LOCALLY ADVANCED OR METASTATIC NSCLC FOLLOWING FAILURE OF EGFR TKI THERAPY MEETS PRE-SPECIFIED PRIMARY ENDPOINT (71KB)
Release Time: 25/08/2026 19:13 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS VACCINE (SYS6057) OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S. (72KB)
Release Time: 20/08/2026 12:20 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Dividend or Distribution (Announcement Form)]
2026 INTERIM DIVIDEND (42KB)
Release Time: 20/08/2026 12:18 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Interim Results / Dividend or Distribution / Closure of Books or Change of Book Closure Period]
2026 INTERIM RESULTS (654KB)
Release Time: 19/08/2026 19:37 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE IB/II CLINICAL TRIAL OF SYS6090 INJECTION FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA OFFICIALLY INITIATED AT THE FIRST CENTRE IN CHINA (73KB)
Release Time: 18/08/2026 18:00 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION FOR ANBENITAMAB (KN026) AND DOCETAXEL FOR INJECTION (ALBUMIN-BOUND) (HB1801) FOR THE FIRST-LINE TREATMENT OF ADVANCED BREAST CANCER ACCEPTED BY THE NMPA (75KB)
Release Time: 17/08/2026 20:18 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Results of a Subsidiary]
UNAUDITED FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE SIX MONTHS ENDED 30 JUNE 2026 (87KB)
Release Time: 12/08/2026 21:13 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Share Scheme]
VOLUNTARY ANNOUNCEMENT - CHANGE OF TRUSTEE OF THE 2018 SHARE AWARD SCHEME (67KB)
Release Time: 12/08/2026 20:16 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - RECEIPT OF US$30 MILLION UPFRONT PAYMENT UNDER THE COLLABORATION, OPTION AND LICENSE AGREEMENT WITH ASTRAZENECA FOR THE DEVELOPMENT OF siRNA DRUGS (71KB)
Release Time: 11/08/2026 20:02 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE I CLINICAL TRIAL OF SYS6063 FOR THE TREATMENT OF RELAPSED, REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS OFFICIALLY INITIATED AT THE FIRST CENTRE IN CHINA (69KB)
Release Time: 10/08/2026 19:06 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Date of Board Meeting]
DATE OF BOARD MEETING (66KB)
Release Time: 10/08/2026 18:57 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - SYS6037 INJECTION (MPOX MRNA VACCINE) OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S. (67KB)
Release Time: 05/08/2026 17:50 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - RECEIPT OF US$10 MILLION MILESTONE PAYMENT UNDER THE STRATEGIC RESEARCH COLLABORATION AGREEMENT WITH ASTRAZENECA (68KB)
Release Time: 05/08/2026 16:30 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ENTERING INTO A JOINT VENTURE CONTRACT WITH ASTRAZENECA IN RELATION TO THE ESTABLISHMENT OF A JOINT VENTURE TO FURTHER DEEPEN STRATEGIC COLLABORATION (71KB)
Release Time: 04/08/2026 18:00 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION FOR ANBENITAMAB (KN026) AND DOCETAXEL FOR INJECTION (ALBUMIN-BOUND) (HB1801) FOR NEOADJUVANT TREATMENT ACCEPTED BY THE NMPA (74KB)
Release Time: 03/08/2026 19:34 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Monthly Returns
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2026 (66KB)
Release Time: 03/08/2026 19:32 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE IB/II CLINICAL TRIAL OF SYS 6090 INJECTION FOR THE TREATMENT OF COLORECTAL CANCER OFFICIALLY INITIATED AT THE FIRST CENTRE IN CHINA (69KB)
Release Time: 31/07/2026 17:56 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF SYS6041 AS A COMBINATION THERAPY FOR THE TREATMENT OF RECURRENT OVARIAN CANCER OFFICIALLY INITIATED AT THE FIRST CENTRE IN CHINA (69KB)
Release Time: 31/07/2026 17:55 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS VACCINE (SYS6057) OBTAINS CLINICAL TRIAL APPROVAL IN CHINA (68KB)
Release Time: 30/07/2026 18:03 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Discloseable Transaction]
DISCLOSEABLE TRANSACTION - ENTERING INTO OF (1) FX SWAP CONTRACT AND (2) FX FORWARD CONTRACTS (110KB)
Release Time: 29/07/2026 20:32 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - CRB-701 (SYS6002) RECEIVES U.S. FDA CLEARANCE FOR THE REGISTRATIONAL TRIAL FOR THE SECOND-LINE TREATMENT OF OROPHARYNGEAL CANCER (73KB)
Release Time: 29/07/2026 20:31 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF SYH2062 INJECTION FOR THE TREATMENT OF ADULT ESSENTIAL HYPERTENSION OFFICIALLY INITIATED AT THE FIRST CENTRE IN CHINA (72KB)
Release Time: 27/07/2026 20:57 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION FOR SIROLIMUS FOR INJECTION (ALBUMIN-BOUND) ACCEPTED BY THE NMPA (74KB)
Release Time: 27/07/2026 20:55 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL TRIAL OF AMMOXETINE HYDROCHLORIDE ENTERIC-COATED TABLETS (HA1406) FOR THE TREATMENT OF PATIENTS WITH DEPRESSION MET THE PRIMARY ENDPOINT (70KB)
Release Time: 27/07/2026 17:33 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Results of a Subsidiary]
INDICATIVE RESULTS OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE SIX MONTHS ENDED 30 JUNE 2026 (77KB)
Release Time: 27/07/2026 17:31 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Profit Warning / Inside Information]
POSITIVE PROFIT ALERT (72KB)
Release Time: 24/07/2026 18:43 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PALIPERIDONE PALMITATE INJECTION RECEIVES MARKETING APPROVAL (68KB)
Release Time: 22/07/2026 21:04 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF SYS6026 INJECTION FOR THE TREATMENT OF HPV TYPE 16- OR 18-RELATED CERVICAL HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESION OFFICIALLY INITIATED IN CHINA (69KB)
Release Time: 17/07/2026 16:49 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION FOR TRASTUZUMAB ENVEDOTIN INJECTION ACCEPTED BY THE NMPA (68KB)
Release Time: 16/07/2026 19:26 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF SIROLIMUS FOR INJECTION (ALBUMIN-BOUND) FOR THE TREATMENT OF EPITHELIOID HAEMANGIOENDOTHELIOMA OFFICIALLY INITIATED AT THE FIRST CENTRE IN CHINA (67KB)
Release Time: 16/07/2026 19:25 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL TRIAL OF SYS6043 FOR THE TREATMENT OF PLATINUM-RESISTANT ADVANCED OVARIAN CANCER, PRIMARY PERITONEAL CANCER, AND FALLOPIAN TUBE CANCER OFFICIALLY INITIATED AT THE FIRST CENTRE IN CHINA (69KB)
Release Time: 14/07/2026 19:00 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - DOCETAXEL FOR INJECTION (ALBUMIN-BOUND) (HB1801) AND ANBENITAMAB (KN026) GRANTED BREAKTHROUGH THERAPY DESIGNATION IN CHINA FOR THE FIRST-LINE TREATMENT OF ADVANCED HER2-POSITIVE BREAST CANCER (72KB)
Release Time: 10/07/2026 22:30 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - RECEIPT OF US$25 MILLION RESEARCH AND DEVELOPMENT MILESTONE PAYMENT UNDER THE STRATEGIC COLLABORATION AND LICENSE AGREEMENT WITH ASTRAZENECA (68KB)
Release Time: 07/07/2026 19:41 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF SYH2070 INJECTION FOR THE TREATMENT OF MIXED HYPERLIPIDAEMIA OFFICIALLY INITIATED AT THE FIRST CENTRE IN CHINA (73KB)
Release Time: 02/07/2026 19:03 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Monthly Returns
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2026 (66KB)
Release Time: 02/07/2026 18:55 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - SYS6043 GRANTED BREAKTHROUGH THERAPY DESIGNATION IN CHINA FOR THE TREATMENT OF PLATINUM-RESISTANT OVARIAN CANCER, PRIMARY PERITONEAL CARCINOMA AND FALLOPIAN TUBE CANCER (76KB)
Release Time: 02/07/2026 18:53 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - IRON SUCROSE INJECTION RECEIVES MARKETING APPROVAL (70KB)
Release Time: 02/07/2026 18:52 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - RECOMBINANT HERPES ZOSTER VACCINE (SYS6052) OBTAINS CLINICAL TRIAL APPROVAL IN CHINA (70KB)
Release Time: 02/07/2026 18:48 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE I CLINICAL STUDY OF SYH2095 TABLETS AS A MONOTHERAPY OR IN COMBINATION REGIMENS FOR THE TREATMENT OF ADVANCED MALIGNANT TUMOURS OFFICIALLY INITIATED IN CHINA (73KB)
Release Time: 02/07/2026 16:30 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - ENTERING INTO COLLABORATION, OPTION AND LICENSE AGREEMENT WITH ASTRAZENECA FOR THE DEVELOPMENT OF siRNA DRUGS (72KB)
Release Time: 30/06/2026 22:06 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL TRIAL OF SYS6010 IN COMBINATION WITH ENLONSTOBART FOR THE ADJUVANT TREATMENT OF RESECTED STAGE II-IIIB NON-SMALL CELL LUNG CANCER WITH ACTIONABLE GENOMIC ALTERATION-NEGATIVE STATUS AND WITHOUT ACHIEVING MPR OFFICIALLY INITIATED IN CHINA (69KB)
Release Time: 26/06/2026 19:19 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Share Scheme / Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT - ON-MARKET PURCHASE OF SHARES PURSUANT TO THE 2026 SHARE AWARD SCHEME (68KB)
Release Time: 26/06/2026 17:57 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL STUDY OF SYS6010 IN COMBINATION WITH ENLONSTOBART FOR THE TREATMENT OF DRIVER GENE-NEGATIVE NON-SMALL CELL LUNG CANCER OFFICIALLY INITIATED IN CHINA (68KB)
Release Time: 25/06/2026 19:43 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Share Scheme / Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT - ON-MARKET PURCHASE OF SHARES PURSUANT TO THE 2026 SHARE AWARD SCHEME (68KB)
Release Time: 23/06/2026 19:02 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Share Scheme / Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT - ON-MARKET PURCHASE OF SHARES PURSUANT TO THE 2026 SHARE AWARD SCHEME (68KB)
Release Time: 22/06/2026 19:09 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Share Scheme / Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT - ON-MARKET PURCHASE OF SHARES PURSUANT TO THE 2026 SHARE AWARD SCHEME (68KB)
Release Time: 22/06/2026 16:39 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Discloseable Transaction]
FURTHER ANNOUNCEMENT - UPDATE ON DISCLOSEABLE TRANSACTION IN RELATION TO THE PROPOSED H SHARE LISTING OF CSPC INNOVATION (74KB)
Release Time: 18/06/2026 17:43 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - NMPA ACCEPTS SECOND MARKETING AUTHORISATION APPLICATION FOR EFMEDAGLUTIDE ALFA INJECTION (76KB)
Release Time: 18/06/2026 17:41 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - NMPA ACCEPTS MARKETING AUTHORISATION APPLICATION FOR SECUKINUMAB INJECTION (85KB)
Release Time: 18/06/2026 17:40 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - OCTREOTIDE LONG-ACTING INJECTION (SYHX2008) OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S. (68KB)
Release Time: 17/06/2026 20:08 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Share Scheme / Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT - ON-MARKET PURCHASE OF SHARES PURSUANT TO THE 2026 SHARE AWARD SCHEME (68KB)
Release Time: 16/06/2026 18:40 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - NMPA ACCEPTS MARKETING AUTHORISATION APPLICATION FOR VALSARTAN AND LEVAMLODIPINE MALEATE TABLETS (SYH9056 TABLETS) (76KB)
Release Time: 16/06/2026 18:38 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Share Scheme / Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT - ON-MARKET PURCHASE OF SHARES PURSUANT TO THE 2026 SHARE AWARD SCHEME (68KB)
Release Time: 15/06/2026 19:31 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PACLITAXEL FOR INJECTION (ALBUMIN-BOUND) (II) RECEIVES MARKETING APPROVAL (70KB)
Release Time: 10/06/2026 19:00 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL STUDY OF ANBENITAMAB (KN026) IN COMBINATION WITH DOCETAXEL FOR INJECTION (ALBUMIN-BOUND) (HB1801) FOR FIRST-LINE TREATMENT OF HER2-POSITIVE ADVANCED BREAST CANCER MEETS PRIMARY ENDPOINT (80KB)
Release Time: 09/06/2026 18:42 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Share Scheme / Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT - ON-MARKET PURCHASE OF SHARES PURSUANT TO THE 2026 SHARE AWARD SCHEME (68KB)
Release Time: 08/06/2026 20:19 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Share Scheme / Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT - ON-MARKET PURCHASE OF SHARES PURSUANT TO THE 2026 SHARE AWARD SCHEME (68KB)
Release Time: 08/06/2026 19:46 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - SEMAGLUTIDE LONG-ACTING INJECTION (SYH9017) OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S. (68KB)
Release Time: 08/06/2026 19:44 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Share Scheme]
VOLUNTARY ANNOUNCEMENT - GRANT OF AWARDED SHARES PURSUANT TO THE 2018 SHARE AWARD SCHEME (77KB)
Release Time: 05/06/2026 17:39 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [List of Directors and their Role and Function]
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS (63KB)
Release Time: 05/06/2026 17:37 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities]
RESIGNATION OF EXECUTIVE DIRECTOR (63KB)
Release Time: 03/06/2026 19:11 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Share Scheme / Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT - ON-MARKET PURCHASE OF SHARES PURSUANT TO THE 2026 SHARE AWARD SCHEME (71KB)
Release Time: 02/06/2026 18:20 Stock Code: 01093 Stock Short Name: CSPC PHARMA Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - FIRST mRNA-LNP-BASED DUAL-TARGET CAR-T CELL INJECTION (SYS6063 INJECTION) OBTAINS CLINICAL TRIAL APPROVAL IN CHINA (69KB)
Showing 100 of 1622 records
Showing 100 of 1622 records
Disclaimer

Information contained in the materials available under the web page containing the hyperlink to this disclaimer is posted on this website for the purpose of providing information to the public in Hong Kong. It is not intended as investment advice and must not be relied on as such. It is the sole responsibility of any person who is located outside of Hong Kong to check and comply with all applicable laws and regulations before accessing and using the materials and information.

Please note that the web page contains materials and information provided to HKEX electronically (including information provided in electronic format) by listed issuers, new listing applicants and relevant parties and there is no agency, employee or partner relationship between HKEX and such parties. HKEX does not assume responsibility for screening, editing or monitoring such materials and the information contained in the materials. The information contained in the materials is not verified by HKEX.

HKEX and/or its subsidiaries take no responsibility for the materials and information available under the web page, make no representation as to their accuracy, reliability, completeness or ownership and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the information. Some materials may contain hyperlinks to external websites or web pages for which HKEX and/or its subsidiaries are not responsible. (Please see HKEX's "Hyperlink Policy").

Nothing herein shall constitute or be considered to be a limitation upon or a waiver of the privileges and immunities of HKEX and its subsidiaries, which are specifically reserved.

Copyright exists in the information and materials available under the web page and may belong to HKEX, to the author or to any other party depending on the circumstances of publications. Reproduction, distribution, use and/or linking without consent from the relevant parties is not permitted.

If you believe or are aware that any information contained in the materials is inaccurate, erroneous, unlawful, obscene, defamatory or infringes any intellectual property rights of a third party, please contact HKEX e-Submission by email at: ESSHotline@hkex.com.hk.